Mark DeStefano

Mark DeStefano

Company: Teva Pharmaceuticals

Job title: Director of Combination Products and Devices R&D

Seminars:

Panel Discussion: Sustainability Strategies for Injectable Device Development 11:30 am

Novel material development selection with cost, biocompatibility and sustainability all in mind to promote the sustainability profile of your device Waste reduction strategies during manufacturing, such as injection moulding and thermos softening plastics to promote the sustainability profile of your deviceRead more

day: Conference Day One

Chair’s Opening Remarks 8:50 am

Read more

day: Conference Day One

Chair’s Closing Remarks & End of Day 1 5:30 pm

Read more

day: Conference Day One

Panel Discussion: Patient Centric Injectable Drug Delivery Improvement & Innovation 1:45 pm

Development of injectable devices capable of delivery drugs at home with minimal pain for the improvement of patient experience Discussion of novel formulations focussed on patient centricity to improve patient experience and compliance New developments in injectable drug delivery to assist in your landscape understanding and in the identification of new technologyRead more

day: Conference Day Two

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.